HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (OTCBB: IPXL.OB) today reported net income for the fourth quarter of 2008 increased 39% to $9.1 million, compared with net income of $6.5 million in the prior year. Reported earnings per diluted share increased 36% to $0.15, compared with earnings per diluted share of $0.11 in the prior year. Cash and short-term investments, net of interest-bearing debt, increased to $99.3 million as of December 31, 2008, compared with $60.2 million as of September 30, 2008, and $53.8 million at December 31, 2007.
